BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  New Study Published in ESMO Open Highlights Guardant Reveal’s Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer

  June 9, 2025

   · 

  4 min read
• Press Releases

  Fable Therapeutics Appoints David J. Baker, PhD, as Chief Scientific Officer

  June 9, 2025

   · 

  2 min read
• Press Releases

  Dilon Technologies, Inc. Closes $9 Million in Growth Capital Financing

  June 9, 2025

   · 

  2 min read
• Press Releases

  Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

  June 9, 2025

   · 

  4 min read
• Press Releases

  Neowise Biotechnology and BeOne Medicines Enter Licensing Agreement to Advance Development of Next-Generation Cell Therapies

  June 9, 2025

   · 

  4 min read
• Press Releases

  Innospera Pharma Appoints Dr. Glenn Crater as Chief Medical Officer to Support Advancement of ING-006 Toward the Clinic

  June 9, 2025

   · 

  2 min read
• Press Releases

  BriefCast Publishes Transcript: PolyPid Ltd. SHIELD II Phase 3 Trial Topline Results Call Transcript

  June 9, 2025

   · 

  12 min read
• Press Releases

  Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2025

  June 9, 2025

   · 

  2 min read
• Press Releases

  Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2025

  June 9, 2025

   · 

  1 min read
• Press Releases

  Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 6, 2025

  June 9, 2025

   · 

  1 min read